Abstract:Background. Disorders in the production of neuroendocrine peptides in the digestive tract can cause changes in, intestinal motility and the formation of visceral hypersensitivity, characteristic of patients with irritable bowel syndrome (IBS). From this standpoint, of particular interest is the study of the role of a number of major endocrine cells (EC) of the colon, secreting motilin, vasoactive intestinal polypeptide, and somatostatin, in IBS. Aims to evaluate the density of ECs with different hormonal activities that secrete motilin, vasoactive intestinal polypeptide and somatostatin in the mucosa of the sigmoid colon in patients with IBS that occurs with constipation and diarrhea. Materials and methods. 85 patients with IBS were examined. The first group included 44 patients with diarrhea (IBSd), the second group included 41 patients with constipation (IBSc). The comparison group consisted of 36 practically healthy people. The diagnosis of IBS was based on the Rome IV criteria. Patients and healthy people were examined according to a single program, including clinical, instrumental (colonoscopy, ultrasound examination of the abdominal organs), laboratory (clinical blood test, feces for calprotectin and antibodies to gliadin in the presence of diarrhea), morphological and immunohistochemical methods. Results. The clinical picture of IBS corresponded to the classical manifestations of this pathology. Among patients with IBSc, there was a more frequent feeling of incomplete emptying of the intestine after defecation, compared with patients with IBSd (p 0.05). Among patients with IBSd, there was a statistically significant increase in the number of ECs producing motilin and vasoactive intestinal polypeptide, as well as a lower density of ECs secreting somatostatin, compared with the control group (p 0.05). In the IBSc group, there was a decrease in the number of ECs producing motilin, vasoactive intestinal polypeptide and an increase in the number of ECs producing somatostatin, compared with the control group (p 0.05). Conclusions. An increase in the number of cells producing motilin, vasoactive intestinal polypeptide and a decrease in the number of cells observed for the production of somatostatin in the mucosa of the sigmoid colon is characteristic of the manifestation of IBSd. At the same time, an increase in ECs secreting motilin, vasoactive intestinal polypeptide and an increase in cellular elements producing somatostatin reveals manifestations of IBSс.

Degranulation of Mast Cell in Ileocecal Colon in Patients with IBS after Pinaverium Bromide Treatment

Pinaverium Bromide Combined with Bifid Triple Viable and Doxepin Therapy in Diarrhea-Dominant Irritable Bowel Syndrome

Effect of Weichang'an Pill on the Treatment of Irritable Bowel Syndrome

Treatment of Irritable Bowel Syndrome with Drotaverine Hydrochloride: A Multicentre Clinical Trial

SF-36 quality of life in effectiveness ssessment for irritable bowel syndrome

Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trial

Efficacy and Safety of Calcium Polycarbophil in the Treatment of Constipation-Predominant Irritable Bowel Syndrome

Treatment of factors that related to diarrhea predominant irritable bowel syndrome

Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea

Efficacy of Pectin in the Treatment of Diarrhea Predominant Irritable Bowel Syndrome

Efficacy and Safety of Otilonium Bromide for Irritable Bowel Syndrome

Short-term and Medium-term Clinical Effect of Liver Dispersing with Spleen Strengthening on Irritable Bowel Syndrome Dominated by Diarrhea

Curative Effect of Dispersing Stagnated Liver-Qi and Invigorating Spleen Versus Invigorating Spleen for Eliminating Dampness on Diarrhea Predominant Irritable Bowel Syndrome.

Mast cell modulation: A novel therapeutic strategy for abdominal pain in irritable bowel syndrome

The Role of Endocrine Cells of the Colon, Secreting Vasoactive Intestinal Polypeptide, Somatostatin and Motilin, in Irritable Bowel Syndrome, Occurring with Diarrhea and Constipation

Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review)

Effect of Acupuncture in Patients With Irritable Bowel Syndrome: A Randomized Controlled Trial

Changes of Colonic 5-Hydroxytryptamine and 5-Hydroxytryptamine3 Receptor in Diarrhea-predominant Irritable Bowel Syndrome

Comparative effect of electroacupuncture and moxibustion on the expression of substance P and vasoactive intestinal peptide in patients with irritable bowel syndrome

Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome

Abdominal Massage Improves the Symptoms of Irritable Bowel Syndrome by Regulating Mast Cells via the Trypase-PAR2-PKC ε Pathway in Rats